To provide comprehensive options for clinical titration and long-term weight management, the Zepbound® single-dose vial pipeline encompasses the complete multi-tier dosing structure. This allows patients to steadily scale their metabolic therapy or settle into an optimized long-term maintenance plateau using the high-value vial format.
The Complete Dosing & Strength Matrix
Zepbound single-dose vials are distributed in 4-vial packs (a 4-week supply). Because they do not feature an integrated auto-injector pen mechanism, the medication is drawn up manually using standard single-use insulin syringes.
| Vial Strength | Volume Concentration | Clinical Dosing Stage | Primary Pack Profile |
| 2.5 mg / 0.5 mL | 2.5 mg per half-milliliter | Introductory Starter Phase (Month 1) | 4 Single-Dose Vials (1 Box) |
| 5 mg / 0.5 mL | 5 mg per half-milliliter | First Maintenance Tier (Month 2+) | 4 Single-Dose Vials (1 Box) |
| 7.5 mg / 0.5 mL | 7.5 mg per half-milliliter | Intermediate Titration Tier | 4 Single-Dose Vials (1 Box) |
| 10 mg / 0.5 mL | 10 mg per half-milliliter | Moderate Maintenance Tier | 4 Single-Dose Vials (1 Box) |
| 12.5 mg / 0.5 mL | 12.5 mg per half-milliliter | Advanced Titration Tier | 4 Single-Dose Vials (1 Box) |
| 15 mg / 0.5 mL | 15 mg per half-milliliter | Maximum Therapeutic Maintenance Tier | 4 Single-Dose Vials (1 Box) |
Key Features & Benefits
-
Complete Escalation Path: Supports the full, standard monthly step-up protocol under precise medical guidance, from initial tolerance building to maximal metabolic saturation.
-
Cost-Effective Choice: Eliminates the complex machinery of auto-retracting pens, providing a lower-cost manufacturing blueprint that translates to increased affordability across all strengths.
-
Flexible Maintenance Baselines: Allows healthcare providers to easily pinpoint a patient’s optimal plateau (such as 5 mg, 10 mg, or 15 mg) for long-term chronic weight management.
-
Identical Active Compound: Delivers the exact same dual GIP/GLP-1 receptor agonist active ingredient (tirzepatide) found in commercial prefilled pens.
Administration & Storage Instructions
-
Manual Dose Preparation: Subcutaneous injection only. A licensed healthcare professional must train you on the precise technique to draw the entire liquid volume out of the vial using a sterile single-use syringe before your initial dose.
-
Weekly Rotation Routine: Inject once weekly on a consistent day, at any time of day, with or without food. Administer into the abdomen, thigh, or upper arm, ensuring strict rotation of injection spots. Never inject into a vein or muscle.
-
Cold Chain Logistics: Unopened vials must be kept refrigerated between 36°F–46°F (2°C–8°C) until the printed expiration date. Do not freeze.
-
Room Temperature Protocol: Vials may be stored at room temperature up to 86°F (30°C) for up to 21 days, provided they are kept inside their original box to guard against direct light. Discard the vial safely immediately after its single use.
Important Safety & Prescription Notice: Prescription Required (Rx Only). Zepbound® carries a boxed warning regarding the potential risk of thyroid C-cell tumors. Do not use if you or anyone in your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Zepbound must not be used concurrently with Mounjaro® or any other GLP-1 receptor agonist medications. The most common side effects across all strengths are gastrointestinal, including nausea, diarrhea, vomiting, constipation, and stomach discomfort. Side effects may become more pronounced during titration steps to higher strengths. All dosing adjustments must be supervised by a licensed medical practitioner.
Reviews
There are no reviews yet.